Literature DB >> 22749378

FOXP3 and TLR4 protein expression are correlated in non-small cell lung cancer: implications for tumor progression and escape.

Hai-ying Fu1, Chun Li, Wei Yang, Xiao-dong Gai, Ting Jia, Yan-ming Lei, Yi Li.   

Abstract

NSCLC (non-small cell lung cancer) is the most common type of lung cancer and usually has poor prognosis. FOXP3 in regulatory T cells (Tregs) and toll-like receptor 4 (TLR4) on some tumor cells are known to be important for tumor escape and clinical tumor formation. Since FOXP3 was found recently in some tumor cells, we speculated if lung tumor cells express FOXP3 and then mimic Tregs to promote tumor escape. As TLR4 induces activation of Tregs, we also hypothesized that FOXP3 and TLR4 may have a correlation in NSCLC progression. The expression levels of FOXP3 and TLR4 protein were detected using immunohistochemistry in 53 postoperative specimens of NSCLC patients and in 15 normal lung tissues from excisions of benign lesion. The relationship between protein expression levels and clinical pathology parameters, as well as the relationship between the expression of FOXP3 and TLR4, were analyzed. FOXP3 and TLR4 expression in NSCLC were significantly elevated as compared to normal lung tissue. FOXP3 expression was closely related with lymph node metastasis and TNM staging, whereas TLR4 expression was closely related with tumor differentiation. The Spearman correlation coefficient indicated a significant positive correlation between FOXP3 and TLR4 expression. These results indicate that FOXP3 and TLR4 may coordinate to play a role in tumor escape and subsequent tumor progression.
Copyright © 2012 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22749378     DOI: 10.1016/j.acthis.2012.06.002

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  25 in total

1.  Aqueous extract of Caesalpinia sappan decelerates allograft rejection by inducing imbalance between CD4(+) CD25(+) T cells and Th17 cells.

Authors:  Chunxia Li; Hui Zhang; Dongqin Gao; Qun Ma; Zhihua Li; Jun Dai; Mingyan Zhang; Chuanping Si
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 2.  TLR4 Polymorphisms and Expression in Solid Cancers.

Authors:  Nilesh Pandey; Alex Chauhan; Neeraj Jain
Journal:  Mol Diagn Ther       Date:  2018-12       Impact factor: 4.074

3.  NADPH oxidase 1-dependent ROS is crucial for TLR4 signaling to promote tumor metastasis of non-small cell lung cancer.

Authors:  Xiyu Liu; Changyan Pei; Song Yan; Guifeng Liu; Gang Liu; Wenqing Chen; Youbin Cui; Yahui Liu
Journal:  Tumour Biol       Date:  2015-01-16

Review 4.  Mechanisms of immune response regulation in lung cancer.

Authors:  Joanna Domagala-Kulawik; Iwona Osinska; Grazyna Hoser
Journal:  Transl Lung Cancer Res       Date:  2014-02

Review 5.  Beyond chemotherapy and targeted therapy: adoptive cellular therapy in non-small cell lung cancer.

Authors:  Junying Wang; Xueju Wang
Journal:  Mol Biol Rep       Date:  2014-06-27       Impact factor: 2.316

6.  Detection and significance of TregFoxP3(+) and Th17 cells in peripheral blood of non-small cell lung cancer patients.

Authors:  Sha Li; Yan Li; Xun Qu; Xiaolin Liu; Jing Liang
Journal:  Arch Med Sci       Date:  2014-05-13       Impact factor: 3.318

Review 7.  Toll-like receptor-4 modulation for cancer immunotherapy.

Authors:  Shanjana Awasthi
Journal:  Front Immunol       Date:  2014-07-25       Impact factor: 7.561

8.  FOXP3 facilitates the invasion and metastasis of non-small cell lung cancer cells through regulating VEGF, EMT and the Notch1/Hes1 pathway.

Authors:  Chun Li; Hefei Wang; Hui Fang; Chengyuan He; Yijie Pei; Xiaodong Gai
Journal:  Exp Ther Med       Date:  2021-07-06       Impact factor: 2.447

Review 9.  Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment.

Authors:  Marlies E Heuvers; Joachim G Aerts; Robin Cornelissen; Harry Groen; Henk C Hoogsteden; Joost P Hegmans
Journal:  BMC Cancer       Date:  2012-12-05       Impact factor: 4.430

10.  Expression of CXC chemokine receptor-4 and forkhead box 3 in neuroblastoma cells and response to chemotherapy.

Authors:  Jing Sun; Chen Feng; Weiwei Liao; Hao Zhang; Suoqin Tang
Journal:  Oncol Lett       Date:  2014-04-03       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.